Kong Xuejun, Hao Shaojun, Li Chongxian, Wang Huamin, Gao Yanling, Su Feng, Wang Ling, Sun Youshu, Zhang Zhengchen
Department of Special Investigation, 371 Central Hospital of PLA, Xinxiang, Henan, China.
Department of Drug and Equipment, 371 Central Hospital of PLA, Xinxiang, Henan, China.
Ann Clin Lab Sci. 2019 May;49(3):361-367.
We aim to investigate the protective effects of compound Cotinus coggygria oral liquid on acute liver injury of mice induced by D-galactosamine (GalN).
Acute liver injury mouse model was established by D-GalN. A total of 72 mice were randomly divided into the blank group, model group constructed by D-GalN, Huganning tablet-treated model group (1.0125 g/kg, as the positive control group), and large (30 ml/kg), medium (15 ml/kg) and small (7.5 ml/kg) doses of compound Cotinus coggygria oral liquid-treated model groups. SPSS 17.0 was used for statistical analysis.
Compared to the blank group, the model group demonstrated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in mice serum and liver homogenate was significantly increased (<0.01), alteration of liver tissue structure and obvious hepatic cytolysis necrosis, indicating successfully establishement of acute liver injury model. Compared with the model group, the liver index is significantly decreased in large and medium doses of compound Cotinus coggygria oral liquid treated groups (<0.05), and the effects of large doses of compound Cotinus coggygria are more significant (<0.01). Furthermore, different doses of compound Cotinus coggygria oral liquid can significantly reduce the activity of mice serum ALT, AST (<0.01). Large and medium doses of compound Cotinus coggygria oral liquid significantly reduce the activities of ALT (<0.01) and AST in liver homogenate (<0.05), and also improve the structure of liver tissues, decreasing the amount of hepatic necrosis, which is associated with liver cell regeneration.
Compound Cotinus coggygria oral liquid has protective effects on mice acute liver injury induced by D-GalN.
探讨复方黄栌口服液对D-氨基半乳糖(GalN)诱导的小鼠急性肝损伤的保护作用。
采用D-氨基半乳糖建立急性肝损伤小鼠模型。将72只小鼠随机分为空白组、D-氨基半乳糖造模的模型组、护肝宁片治疗的模型组(1.0125 g/kg,作为阳性对照组)以及大剂量(30 ml/kg)、中剂量(15 ml/kg)和小剂量(7.5 ml/kg)复方黄栌口服液治疗的模型组。采用SPSS 17.0进行统计分析。
与空白组相比,模型组小鼠血清及肝匀浆中的丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)显著升高(<0.01),肝组织结构改变,肝细胞明显溶解坏死,表明急性肝损伤模型成功建立。与模型组相比,大剂量和中剂量复方黄栌口服液治疗组的肝脏指数显著降低(<0.05),大剂量复方黄栌口服液的效果更显著(<0.01)。此外,不同剂量的复方黄栌口服液均可显著降低小鼠血清ALT、AST的活性(<0.01)。大剂量和中剂量复方黄栌口服液可显著降低肝匀浆中ALT(<0.01)和AST的活性(<0.05),还可改善肝组织结构,减少肝坏死量,这与肝细胞再生有关。
复方黄栌口服液对D-氨基半乳糖诱导的小鼠急性肝损伤具有保护作用。